<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01394432</url>
  </required_header>
  <id_info>
    <org_study_id>RBI-1749</org_study_id>
    <secondary_id>RU8HM86-54N</secondary_id>
    <nct_id>NCT01394432</nct_id>
  </id_info>
  <brief_title>&quot;ESTIMATION Study&quot; for Endocardial Mesenchymal Stem Cells Implantation in Patients After Acute Myocardial Infarction</brief_title>
  <acronym>ESTIMATION</acronym>
  <official_title>Endocardial Mesenchymal Stem Cells Implantation in Patients After Acute Myocardial Infarction</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Meshalkin Research Institute of Pathology of Circulation</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Meshalkin Research Institute of Pathology of Circulation</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators hypothesised that endocardial stem cells implantation following after&#xD;
      percutaneous coronary intervention (PCI) could reduce the scar formation and increase reverse&#xD;
      remodeling in patients with primary acute myocardial infarction.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>July 2011</start_date>
  <completion_date type="Anticipated">November 2016</completion_date>
  <primary_completion_date type="Actual">November 2012</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Reduction in left ventricle systolic volume on 15% mesured by MRI</measure>
    <time_frame>12 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>All-cause death</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>number of patients with thromboembolic events</measure>
    <time_frame>12 months</time_frame>
    <description>comparison the number of patients with thromboembolic events between two groups</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>number of heart failure hospitalizations</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Distance during 6-minute walking test</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>number of patients with life-threatening arrhythmias</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>BNP level</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SPECT and Echo data</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Acute Myocardial Infarction</condition>
  <condition>Heart Failure</condition>
  <arm_group>
    <arm_group_label>Group 1 (PCI+SC implantation)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Endocardial Stem cells implantation with Noga system</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 2 (PCI+Placebo)</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>PCI and Stem Cells or Placebo injections</intervention_name>
    <description>Conventional percutaneous coronary intervention after acute myocardial infarction. Harvest of bone marrow from iliac crest. Mesenchymal autologous stem cells preparation (7-10 days after PCI). LV mapping with Noga system (7-10 days after PCI). Randomization 1:1. Stem Cells or placebo implantation.</description>
    <arm_group_label>Group 1 (PCI+SC implantation)</arm_group_label>
    <arm_group_label>Group 2 (PCI+Placebo)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients with acute Q-wave myocardial infarction after thrombolitic therapy during&#xD;
             6-36 hours from the onsent of signs&#xD;
&#xD;
          -  Oclusion or significant stenosis of infarct-related left anterior descending artery&#xD;
             (LAD)&#xD;
&#xD;
          -  Left ventricle ejection fraction (LVEF) &lt; 50% measured by Echo&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Thrombolysis of pyrrolase or streptokinase&#xD;
&#xD;
          -  Surgical unsignificant stenosis of LAD&#xD;
&#xD;
          -  Indications for CABG&#xD;
&#xD;
          -  Cardiogenic shock&#xD;
&#xD;
          -  Uncontrolled hypertension&#xD;
&#xD;
          -  Thrombocytopenia&#xD;
&#xD;
          -  Ongoing bleeding&#xD;
&#xD;
          -  Anemia &lt; 100 g/l&#xD;
&#xD;
          -  Oncology&#xD;
&#xD;
          -  Patients, who required anticoagulation therapy at the time of inclusion&#xD;
&#xD;
          -  Obesity, BMI&gt;40&#xD;
&#xD;
          -  Severe comorbidities&#xD;
&#xD;
          -  Unwillingness to participate&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Evgeny A Pokushalov, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>State Research Institute of Circulation Pathology</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Evgeny Pokushalov, MD</last_name>
    <phone>+79139254858</phone>
    <email>E.Pokushalov@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Alexander Romanov, MD</last_name>
    <phone>+79137172652</phone>
    <email>abromanov@mail.ru</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>State Research Institute of Circulation Pathology</name>
      <address>
        <city>Novosibirsk</city>
        <zip>630055</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Evgeny Pokushalov, MD</last_name>
      <phone>+79139254858</phone>
      <email>E.Pokushalov@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Alexander Romanov, MD</last_name>
      <phone>+79137172652</phone>
      <email>abromanov@mail.ru</email>
    </contact_backup>
    <investigator>
      <last_name>Evgeny Pokushalov, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Alexander Romanov, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Igor Grazhdankin, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Russian Federation</country>
  </location_countries>
  <verification_date>September 2015</verification_date>
  <study_first_submitted>July 8, 2011</study_first_submitted>
  <study_first_submitted_qc>July 13, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 14, 2011</study_first_posted>
  <last_update_submitted>September 21, 2015</last_update_submitted>
  <last_update_submitted_qc>September 21, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 23, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Endocardial Stem Cells Injection</keyword>
  <keyword>Percutaneous Coronary Intervention</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Myocardial Infarction</mesh_term>
    <mesh_term>Infarction</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

